Hide metadata

dc.date.accessioned2021-02-08T20:05:04Z
dc.date.available2021-02-08T20:05:04Z
dc.date.created2020-04-30T17:30:37Z
dc.date.issued2020
dc.identifier.citationByskov, Kristina Etscheid, Michael Kanse, Sandip . Cellular effects of factor VII activating protease (FSAP). Thrombosis Research. 2020, 188, 74-78
dc.identifier.urihttp://hdl.handle.net/10852/83029
dc.description.abstractFactor VII activating protease (FSAP) is a circulating serine protease of broad specificity that is likely to be involved in many pathophysiological processes. The activation of the circulating zymogen form of FSAP by histones, released from damaged cells, underlines its roles in regulating host responses to tissue damage and inflammation. Some of the direct cellular effects of FSAP are mediated through protease-activated receptors (PARs). Knock-down of each one of the four PARs in endothelial cells indicated that PAR-1 and -3 are involved in regulating endothelial permeability in response to FSAP. Overexpression of PARs in cell lines led to the conclusion that PAR-2 and -1 were the main receptors for FSAP. Studies with synthetic peptides and receptor mutants demonstrate that FSAP cleaves PAR-1 and -2 at their canonical cleavage site. However, PAR-1 is not activated by FSAP in all cells, which may be related to other, as yet, undefined factors. Inhibition of apoptosis by FSAP is mediated through PAR-1 and was observed in neurons, astrocytes and A549 cells. FSAP also mediates cellular effects by modulating the activity of growth factors, generation of bradykinin, C5a and C3a generation or histone inactivation. These cellular effects need to be further investigated at the in vivo level.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleCellular effects of factor VII activating protease (FSAP)
dc.typeJournal article
dc.creator.authorByskov, Kristina
dc.creator.authorEtscheid, Michael
dc.creator.authorKanse, Sandip
cristin.unitcode185,51,12,14
cristin.unitnameVaskulær patofysiologi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin1808961
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Thrombosis Research&rft.volume=188&rft.spage=74&rft.date=2020
dc.identifier.jtitleThrombosis Research
dc.identifier.volume188
dc.identifier.startpage74
dc.identifier.endpage78
dc.identifier.doihttps://doi.org/10.1016/j.thromres.2020.02.010
dc.identifier.urnURN:NBN:no-85829
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0049-3848
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/83029/2/Byskov%2BT%2Band%2BH.pdf
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International